Details of the Drug-Related molecule(s) Interaction Atlas

General Information of Drug (ID: DM5LM3O)

Drug Name

IONIS-DNM2-2.5Rx Drug Info

Indication

Disease Entry	ICD 11	Status	REF
Centronuclear myopathy	8C72.01	Phase 2	[1]

Cross-matching ID

Molecule-Related Drug Atlas

Molecule Type:

DTT

Drug Status:

Clinical Trial Drug(s)

Download the Complete Related Drug List

Drug(s) Targeting DNM2 messenger RNA (DNM2 mRNA)

Drug Name	Drug ID	Indication	ICD 11	Highest Status	REF
DYN101	DMVGAI4	Congenital structural myopathy	8C72.0	Phase 1/2	[2]
------------------------------------------------------------------------------------

Molecular Interaction Atlas of This Drug

Molecular Interaction Atlas

Download the Complete Interaction Atlas for Visualization in Cytoscape

Drug Therapeutic Target (DTT)

References

1	Clinical pipeline report, company report or official report of Ionis Pharmaceuticals.
2	Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2023. Adis Insight